Complications About Vaginal Mesh you Should Worry About
Suffering from complications caused by vaginal mesh? Is your daily life disturbed? Is the severe pain disrupting your work or other daily activities? Concerned about transvaginal mesh complications associated with treatments for pelvic floor disorders? Here's what you need to know.
Pelvic organ prolapse (POP) is one of the most common reasons for women to have surgery, with approximately 200,000 inpatient surgical procedures performed for POP in the U.S. each year. A woman’s risk of requiring surgery for prolapse is approximately 10 percent. Of those who have surgery, 13 percent will require a repeat operation within five years and as many as 30 percent will undergo another surgery for prolapse or a related condition at some point during their life.
In the past several years, there was an increase in the use of synthetic and biologic mesh for transvaginal prolapse surgery. This was largely driven by the availability and marketing of commercially available pre-packed mesh products or “mesh kits” for prolapse. Unfortunately, an increasing number of women report serious vaginal mesh complications that severely impact their quality of life.
How is surgical mesh used to treat pelvic floor disorders?
• Pelvic organ prolapse (POP). When the muscles and ligaments supporting a woman's pelvic organs weaken, the pelvic organs can slip out of place (prolapse). To treat POP, surgical mesh can be implanted to reinforce the weakened vaginal wall. Surgery can be done through the abdomen (transabdominal) or through the vagina (transvaginal).
• Stress urinary incontinence (SUI). This is the unintentional loss of urine due to a physical movement or activity — such as coughing, sneezing, running or heavy lifting — that puts pressure (stress) on your bladder. Surgical mesh can be implanted through the vagina to support the urethra or bladder neck. This is known as a midurethral sling or a mesh sling procedure.
Most frequent complications caused by transvaginal mesh
In 2011, the U.S. Food and Drug Administration (FDA) issued a safety communication stating that the use of transvaginal mesh may put women at a higher risk of complications without increased benefit to their quality of life. This is what has sparked a large number of television commercials about the issue.
The most frequent complications noted in the FDA statement included infection, pain, urinary problems, vaginal scarring and recurrence of prolapse and/or incontinence. Another complication cited by the FDA was erosion, in which the mesh gradually dislodges from the vaginal wall where it was implanted and moves into the surrounding tissue and organs. Erosion is also called extrusion or exposure when the mesh protrudes from the opening of the vagina.
The FDA also noted some cases of vaginal scarring and mesh erosion led to a significant decrease in patient quality of life due to discomfort and pain, including painful intercourse (dyspareunia).
In case you have suffered any of these transvaginal mesh complications, contact Settle Our TVM on www.settleourtvm.com or at 1-888-994-2165 for details.
Pelvic organ prolapse (POP) is one of the most common reasons for women to have surgery, with approximately 200,000 inpatient surgical procedures performed for POP in the U.S. each year. A woman’s risk of requiring surgery for prolapse is approximately 10 percent. Of those who have surgery, 13 percent will require a repeat operation within five years and as many as 30 percent will undergo another surgery for prolapse or a related condition at some point during their life.
In the past several years, there was an increase in the use of synthetic and biologic mesh for transvaginal prolapse surgery. This was largely driven by the availability and marketing of commercially available pre-packed mesh products or “mesh kits” for prolapse. Unfortunately, an increasing number of women report serious vaginal mesh complications that severely impact their quality of life.
How is surgical mesh used to treat pelvic floor disorders?
• Pelvic organ prolapse (POP). When the muscles and ligaments supporting a woman's pelvic organs weaken, the pelvic organs can slip out of place (prolapse). To treat POP, surgical mesh can be implanted to reinforce the weakened vaginal wall. Surgery can be done through the abdomen (transabdominal) or through the vagina (transvaginal).
• Stress urinary incontinence (SUI). This is the unintentional loss of urine due to a physical movement or activity — such as coughing, sneezing, running or heavy lifting — that puts pressure (stress) on your bladder. Surgical mesh can be implanted through the vagina to support the urethra or bladder neck. This is known as a midurethral sling or a mesh sling procedure.
Most frequent complications caused by transvaginal mesh
In 2011, the U.S. Food and Drug Administration (FDA) issued a safety communication stating that the use of transvaginal mesh may put women at a higher risk of complications without increased benefit to their quality of life. This is what has sparked a large number of television commercials about the issue.
The most frequent complications noted in the FDA statement included infection, pain, urinary problems, vaginal scarring and recurrence of prolapse and/or incontinence. Another complication cited by the FDA was erosion, in which the mesh gradually dislodges from the vaginal wall where it was implanted and moves into the surrounding tissue and organs. Erosion is also called extrusion or exposure when the mesh protrudes from the opening of the vagina.
The FDA also noted some cases of vaginal scarring and mesh erosion led to a significant decrease in patient quality of life due to discomfort and pain, including painful intercourse (dyspareunia).
In case you have suffered any of these transvaginal mesh complications, contact Settle Our TVM on www.settleourtvm.com or at 1-888-994-2165 for details.
Comments
Post a Comment